Itraconazolo Sandoz (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a cytochrome P450 isoform essential for converting lanosterol to ergosterol. By preventing ergosterol synthesis, the drug disrupts fungal cell‑membrane integrity, leading to inhibited growth and eventual death of susceptible fungi.

The specific dose and treatment duration are determined by the prescribing clinician based on the type and severity of the fungal infection, patient weight, renal and hepatic function, and any concomitant medications. Patients should follow the prescriber’s instructions exactly.

Safety data for itraconazole in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

The most common alternative is fluconazole, another azole antifungal. Itraconazole has a broader spectrum against dermatophytes, dimorphic fungi, and some molds, while fluconazole is more active against Candida species and has fewer drug‑interaction concerns. Itraconazole’s longer half‑life allows once‑daily dosing for many indications, but it requires careful monitoring for hepatic and cardiac effects.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging to protect it from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Itraconazolo Sandoz is taken orally, usually with food or a full glass of water to enhance absorption. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious adverse events include hepatotoxicity (elevated liver enzymes or hepatitis), severe skin reactions such as Stevens‑Johnson syndrome, congestive heart failure or worsening of existing heart failure, and significant electrolyte disturbances like hypokalemia. Patients should report any unexplained jaundice, rash, shortness of breath, or swelling promptly.

Itraconazolo Sandoz should be avoided in individuals with known hypersensitivity to itraconazole or any component of the formulation, patients with severe hepatic impairment, and those with established congestive heart failure. Caution is also advised for patients taking medications that strongly interact with CYP3A4.